Novartis is eyeing an FDA filing for a second drug in immunoglobulin A nephropathy (IgAN), as the Swiss pharma goes all-in on the rare autoimmune kidney disease from three different angles.
HC Wainwright Weighs in on Travere Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:TVTX) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
FY2026 Earnings Forecast for Travere Therapeutics, Inc. Issued By Wedbush (NASDAQ:TVTX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Brokers Reduce Earnings Estimates for Travere Therapeutics, Inc. (NASDAQ:TVTX) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its price objective increased by HC Wainwright from $17.00 to $19.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 252.50% from the company’s current price. HC […]